Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildaspec M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Spectra Therapeutics Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildaspec M 500mg/50mg Tablet

Combivir-M 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially minimizing the risk of cardiovascular events. Combivir-M 500mg/50mg may be administered independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and current medications. Consuming the tablets with food mitigates gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. This treatment regulates blood sugar, preventing future complications. Adherence to your physician's dietary and exercise plan is vital. Lifestyle choices significantly impact diabetes management. Common adverse reactions include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its recognition and management. This medication isn't universally appropriate. Inform your doctor of any history of renal, hepatic, or cardiac disease, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Interactions with other medications are possible; therefore, disclose your entire medication regimen for safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and glucose levels throughout treatment.

Primary Ingredients of Vildaspec M 500mg/50mg Tablet

No text provided to rephrase.

Uses of Vildaspec M 500mg/50mg Tablet

Managing Type 2 diabetes

Major Benefits of Vildaspec M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. The Vildaspec M 500mg/50mg Tablet should be administered with a meal.

Common Side effects of Vildaspec M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildaspec M 500mg/50mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Vildaspec M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Vildaspec M 500mg/50mg Tablet works:

Vildaspec M, a 500mg/50mg tablet, contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Vildaspec M 500mg/50mg Tablets should not be taken together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildaspec M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Vildaspec M 500mg/50mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildaspec M 500mg/50mg tablets, as dose modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

The use of Vildaspec M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vildaspec M 500mg/50mg Tablet :

Should you forget to take a Vildaspec M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage routine. Avoid taking a double dose.

Facts to Know About Vildaspec M 500mg/50mg Tablet

LabelValue
Developing Good Habits No.
Type of Treatment Diabetes Treatment

FAQs on Vildaspec M 500mg/50mg Tablet

Vildaspec M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vildaspec M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Vildaspec M 500mg/50mg Tablets are contraindicated in patients with known allergies to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Vildaspec M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildaspec M 500mg/50mg Tablets can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vildaspec M 500mg/50mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildaspec M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper usage, you may experience side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent issues to your physician.
Vildaspec M 500mg/50mg Ta...
66
MRP 76
13% off